<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5-antioxidants-10-00099">
 <label>5.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bethel</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Engel</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Stevens</surname>
    <given-names>S.R.</given-names>
   </name>
   <name>
    <surname>Lokhnygina</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Ding</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Josse</surname>
    <given-names>R.G.</given-names>
   </name>
   <name>
    <surname>Alvarsson</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hramiak</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Green</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Peterson</surname>
    <given-names>E.D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Progression of glucose-lowering diabetes therapy in TECOS</article-title>
  <source>Endocrinol. Diabetes Metab.</source>
  <year>2019</year>
  <volume>2</volume>
  <fpage>e00053</fpage>
  <pub-id pub-id-type="doi">10.1002/edm2.53</pub-id>
  <pub-id pub-id-type="pmid">30815579</pub-id>
 </element-citation>
</ref>
